Open-science publisher Frontiers has launched FAIR² Data Management, an integrated platform designed to address the significant challenge of scientific data loss and underutilisation. The service combines artificial intelligence with established data management protocols to streamline how research data is stored, shared, and reused across scientific disciplines.
Scientists at the University of Cambridge have created three-dimensional embryo-like structures from human stem cells that spontaneously produce blood cells, offering a new window into early human development and a potential source of cells for transplantation. The structures, called ‘hematoids’, develop beating heart cells and blood stem cells without requiring the complex cocktails of growth […]
HemostOD, a Swiss preclinical-stage company developing ex vivo manufactured universal human blood platelets, has closed a CHF 4.3 million seed extension financing round to advance pre-IND development and establish commercial-scale production capabilities. The funding round was co-led by Polytech Ventures and Orenok Holdings, with participation from the Lichtsteiner Foundation and private investors.
San Diego biotech company Replicate Bioscience has entered into a multi-year research collaboration with pharmaceutical giant Novo Nordisk to develop self-replicating RNA (srRNA) therapeutics targeting obesity, type 2 diabetes, and other cardiometabolic conditions. The partnership combines Replicate’s proprietary srRNA platform technology with Novo Nordisk’s expertise in metabolic disease to create a new class of therapeutic […]
Integrated DNA Technologies (IDT) has announced a strategic partnership with Hamilton Company to develop automated comprehensive genomic profiling workflows for cancer research and other genomic applications. The collaboration will integrate IDT’s customisable NGS research components with Hamilton’s precision liquid handling platforms.
Revvity has announced a comprehensive initiative to expand early detection capabilities for type 1 diabetes, combining in vitro diagnostic assay development with laboratory testing services in collaboration with Sanofi. The programme centres on advancing the company’s existing research-use autoantibody testing platform towards regulatory approval and broader clinical implementation.
Bio-Rad Laboratories has secured exclusive European distribution rights for Gencurix’s CE-IVD Droplex digital PCR oncology testing kits, marking a significant expansion of the companies’ existing collaboration in molecular diagnostics.
SPT Labtech and Agilent Technologies have announced the release of automated target enrichment protocols for the firefly®+ platform, designed to streamline genomic sequencing workflows in clinical research, oncology, and precision medicine applications. The protocols, which integrate Agilent’s SureSelect Max DNA Library Prep Kit with SPT Labtech’s liquid handling automation, are now available to all firefly+ […]
PromoCell GmbH, the Heidelberg-based manufacturer of primary human cells and specialised cell culture media, has announced its entry into the Good Manufacturing Practice (GMP) arena with a new service portfolio designed for cell-based therapy and regenerative medicine applications. The company debuted its Custom GMP Cell Culture Media Services at the 32nd European Society of Gene […]
BioMed X has launched XFem Labs, a dedicated women’s health research and development accelerator at its Heidelberg facility, marking a strategic expansion of the institute’s translational research portfolio. The initiative, backed by a $2 million grant from the Gates Foundation, will focus on addressing critical gaps in women’s healthcare, with particular emphasis on accessible contraceptive […]
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
